Perceptic

Investor: Accel, Air Street Capital, Elder Gull

Perceptic, an AI company focused on drug discovery, has successfully secured a £9m seed funding round. This investment will fuel the acceleration of its platform designed to unify research, development, and clinical decision-making throughout the drug lifecycle.Summary of transaction details:Value: £9mSector: Healthcare & Biotech, DeepTech & AIAdvisor: Not mentionedKey Entities: Target: Perceptic; Lead Investors: Accel, Air Street Capital, Elder GullLocation: Not specified in the articleNote: This seed funding round highlights growing investor confidence in AI solutions that address fundamental inefficiencies in complex industries like pharmaceuticals. Perceptic's unique approach aims to integrate disparate data streams and insights, promising to significantly streamline the drug development process and improve outcomes.